GP2 and infection: However, additional human antibody sites within the core/stalk, GP1, and GP2 as well as the glycan cap have also been described following infection [53, 54], suggesting a more complex picture of immunoreactivity against EBOV GP and underscoring exactly which regions on GP are truly immunodominant in humans that are yet to be fully characterized.